Cryoport, Inc.·4

Jun 8, 9:07 PM ET

Hariri Robert J 4

Research Summary

AI-generated summary

Updated

Cryoport (CYRX) Director Robert J. Hariri Receives Restricted Stock Award

What Happened

  • Robert J. Hariri, a director of Cryoport, was awarded equity on June 5, 2026. The Form 4 reports two grants: 10,350 restricted stock rights (acquired at $0.00) and 16,077 derivative awards (acquired at $0.00). No cash was paid for these awards; total immediate cash consideration reported is $0.

Key Details

  • Transaction date: June 5, 2026. Filing date: June 8, 2026 (timely filing).
  • Award amounts and prices: 10,350 shares @ $0.00 (restricted stock rights); 16,077 derivative award units @ $0.00.
  • Total awards granted: 26,427 shares/rights.
  • Shares owned after the transaction: Not specified in the supplied filing details.
  • Footnotes:
    • F1: The 10,350 restricted stock rights vest in full on June 5, 2027 and will convert one-for-one into common shares upon vesting.
    • F2: The 16,077 derivative awards vest in installments: 1/12th of the options vest on the 5th of each month for 12 months beginning July 5, 2026.
  • Transaction code: A (grant/award).

Context

  • These are compensation grants (awards), not open-market purchases or sales. Grants at $0 often reflect standard equity compensation and do not require immediate cash outlay; they vest over time and only become owned shares as specified by the vesting terms. Such awards are common for directors and do not by themselves indicate a buy/sell signal.